Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8231989 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 7 Pages |
Abstract
Triple therapy with RCT and cetuximab seems to be feasible, with no unexpected toxicity. Early response assessment (TRG), however, suggests subadditive interaction. A longer follow-up (and finally randomized trials) is needed to draw any firm conclusions with respect to local and distant failure rates.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Christian M.D., Dirk M.D., Kathrin M.D., Torsten M.D., Matthias M.D., Rainer M.D., Rolf M.D., Axel Ph.D., Claus M.D.,